Original Supply: Biopharmaceuticals Market
Get Now: Market place Analysis
BIOPHARMA analyzes the U.S. Biopharmaceuticals Market and its growth factors, with particular emphasis on the top firms in the field and their solution pipeline. The report also analyses the current trends and focus of the U.S. biopharmaceutical industry and the challenges faced by the industry. It also provides profiles of the key organizations participating in the United States industry.
Browse market data tables and in-depth TOC on U.S. Biopharmaceutical Industry – Trends, Forecast, Competitors & Strategic Analysis (2009 – 2016)
Early buyers will get 10% customization of reports.
The U.S. biopharmaceuticals market place is expected to increase to $ 144 billion by 2016. This growth is expected as a outcome of the launch of new products, approval of new indications for existing therapies and drugs, and boost in population aged 65 years and above. From 2009 to 2016 the U.S. industry revenues are forecasted to grow at a compound annual growth price (CAGR) of 11.two%.
This research report analyzes the U.S. biopharmaceuticals industry and its growth elements, with specific emphasis on prime firms in the field and their product pipeline. Although it looks at the overall industry size and presents forecast till 2016.
A crucial focus of the report is the escalating role of biopharmaceutical products. The increasing interest in biotechnology development has led to the metamorphosis of the pharmaceutical industry, resulting in the subset sector of biopharmaceuticals. The big players in the pharma industry, such as Pfizer, Merck, and Novartis, have been the very first handful of to reap the benefits of investing in biotechnology through both organic as nicely as inorganic development mechanisms.
Market place forecasts contain the biopharmaceuticals currently in the industry as nicely as these projected to enter the market by the end of the forecast period in 2016. Market challenges, drivers, and restraints have also been identified and assessed. Chosen late stage pipeline analysis is also included.
This report analyzes the biopharmaceutical industry’s products, characteristics, companies, industry size and potential and patent portfolios. The effect of the Medicare and Medicaid policies and individual strategy behaviors on the biopharmaceutical sector is also discussed.
To define and measure the biopharmaceutical industry in the U.S.
To identify the main drivers, restraints, and possibilities in the biopharmaceutical marketplace.
To recognize and analyze comprehensively the biopharmaceutical market structure with respect to the factors influencing industry growth and market-certain challenges.
To analyze the trends and offer the forecasts for the biopharmaceutical market and its segments with respect to different geographies.
To recognize the significant stakeholders in the biopharmaceutical industry and draw a competitive landscape.
To comprehend the regulatory framework, patient security and pricing issues of the biopharmaceutical market place.
Scope of the report
Market place Overview
This section discusses the industry definition of U.S. biopharmaceutical industry. This section also discusses the way industry is segmented and the methodology as nicely as the assumptions regarded for forecasting the revenues for the all the person product/drug class segments.
This analysis service covers biopharmaceuticals and their effect on the U.S. healthcare market place.
Items integrated in this study by their market segmentation:
Gene and Cell therapies, which includes “Antisense Therapies”
PEH: Proteins, Enzymes, and Hormones
Other folks: Blood and Allergenic elements and others.
Products not included:
Biosurgical products like tissue grafts and sealants
Biologics employed for diagnostic purposes
This section discusses the present trends and focus of the U.S. biopharmaceutical marketplace and the challenges faced by the sector. Other sections include market evaluation, patent analysis and competitive landscape.
This section offers the firm profiles of significant organizations participating in the U.S. biopharmaceutical market. Business profiles include a short overview of the firm, primary enterprise, methods followed and developments.
Analyst Briefing Presentation on U.S. Biopharmaceutical Marketplace – Trends, Forecast, Competition & Strategic Evaluation (2009 – 2016) to be held on 14 Dec 2010
The CMF practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on U.S. Biopharmaceutical Market place – Trends, Forecast, Competitors & Strategic Analysis (2009 – 2016) to be held on 14 Dec 2010. The briefing will cover an analysis of trends and current focus of the U.S. biopharmaceutical marketplace and the challenges faced by the industry. The impact of biopharmaceuticals on the U.S. healthcare market place will also be discussed during the briefing.
To register for this briefing, please click here
MarketsandMarkets (M&M) is a international marketplace investigation and consulting company based in the U.S. We publish strategic advisory reports and serve as a enterprise intelligence partner to Fortune 500 businesses across the planet. MarketsandMarkets also gives multi-client reports, company profiles, databases, and custom investigation solutions.
M&M Banking and Economic Services practice recognizes the challenges that monetary institutions face bringing the right products to market. Our reports and consulting practice supply a special viewpoint permitting the economic institution to see and knowledge the greatest way to obtain their solution objectives. By way of a mix of case research, main analysis, and business modeling we provide a 360° view to recognize how you can produce, capture, and maintain the worth of your item and out believe the competitors.
7557 Rambler road,
Suite 727, Dallas, TX 75231
Email: [email protected]